Suchergebnisse - "Visanji, Naomi P"

PubPharm (19)

1

Prevalence and Distribution of Lewy Pathology in a Homeless Population

enthalten in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques | 2023

von Danics, K. | Visanji, N. | Ichimata, S. | +3

2

Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease : A Surgicogenomic Approach

enthalten in: Journal of Parkinson's disease | 2022

von Visanji, N. | Ghani, M. | Yu, E. | +21

3

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

enthalten in: Molecular neurodegeneration | 2021

von Chen, K. | Menezes, K. | Rodgers, J. | +23

4

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

enthalten in: Molecular neurodegeneration | 2021

von Chen, K. | Menezes, K. | Rodgers, J. | +23

5

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

enthalten in: Molecular neurodegeneration | 2021

von Chen, K. | Menezes, K. | Rodgers, J. | +23

6

Emerging drugs for the treatment of L-DOPA-induced dyskinesia : an update

enthalten in: Expert opinion on emerging drugs | 2020

von AlShimemeri, S. | Fox, S. | Visanji, N.

7

Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update

enthalten in: Expert opinion on emerging drugs | 2020

von AlShimemeri, S. | Fox, S. | Visanji, N.

8

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease

enthalten in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society | 2019

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9

9

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

enthalten in: Translational neurodegeneration | 2019

von Visanji, N. | Lang, A. | Kovacs, G.

10

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease

enthalten in: Clinical autonomic research | 2019

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9